| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
60,594 |
57,308 |
$2.83M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
17,553 |
17,100 |
$1.73M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
23,319 |
22,172 |
$1.68M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
17,185 |
16,778 |
$1.56M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
10,098 |
9,640 |
$957K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,266 |
3,061 |
$325K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
10,370 |
9,881 |
$138K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,988 |
1,964 |
$77K |
| 90686 |
|
10,982 |
10,753 |
$61K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
3,499 |
3,282 |
$55K |
| 90734 |
|
1,385 |
1,324 |
$50K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,332 |
1,282 |
$44K |
| 90670 |
|
6,638 |
6,572 |
$43K |
| 90698 |
|
9,275 |
9,149 |
$40K |
| 99188 |
|
1,585 |
1,520 |
$29K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
608 |
546 |
$26K |
| 90710 |
|
2,392 |
2,354 |
$26K |
| 90651 |
|
3,437 |
3,398 |
$25K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
361 |
353 |
$20K |
| 90633 |
|
5,173 |
5,085 |
$20K |
| 90680 |
|
5,881 |
5,806 |
$17K |
| 90744 |
|
4,481 |
4,438 |
$15K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
315 |
311 |
$14K |
| G0008 |
Administration of influenza virus vaccine |
832 |
711 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
804 |
710 |
$12K |
| 90696 |
|
2,365 |
2,316 |
$12K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
584 |
566 |
$11K |
| 90715 |
|
1,940 |
1,913 |
$8K |
| 99215 |
Prolong outpt/office vis |
90 |
83 |
$8K |
| 90707 |
|
2,161 |
2,120 |
$7K |
| 90716 |
|
2,390 |
2,352 |
$7K |
| 99177 |
|
3,740 |
3,636 |
$5K |
| 96127 |
|
1,710 |
1,659 |
$5K |
| 92551 |
|
3,071 |
2,982 |
$5K |
| 90656 |
|
1,796 |
1,794 |
$5K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
176 |
173 |
$4K |
| 90620 |
|
1,334 |
1,307 |
$4K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
1,127 |
1,054 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
206 |
100 |
$3K |
| 90461 |
|
39 |
39 |
$2K |
| 0002A |
|
102 |
74 |
$2K |
| 90688 |
|
128 |
124 |
$2K |
| 0001A |
|
37 |
35 |
$2K |
| 0071A |
|
459 |
459 |
$1K |
| 90677 |
|
2,668 |
2,505 |
$1K |
| 90685 |
|
43 |
39 |
$914.84 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,437 |
1,186 |
$558.32 |
| 92552 |
|
532 |
527 |
$555.71 |
| 0072A |
|
408 |
408 |
$390.00 |
| 96161 |
|
208 |
206 |
$383.18 |
| 96160 |
|
1,679 |
1,643 |
$266.58 |
| 83655 |
|
667 |
655 |
$248.76 |
| 80061 |
Lipid panel |
244 |
241 |
$120.84 |
| 90474 |
|
12 |
12 |
$120.00 |
| 99173 |
|
164 |
164 |
$92.82 |
| 85018 |
|
15 |
13 |
$26.58 |
| 90619 |
|
1,932 |
1,907 |
$0.00 |
| 0081A |
|
25 |
25 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
55 |
50 |
$0.00 |
| 36416 |
|
66 |
62 |
$0.00 |
| 90381 |
|
172 |
171 |
$0.00 |
| 0052A |
|
13 |
13 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
68 |
68 |
$0.00 |
| 91319 |
|
48 |
48 |
$0.00 |
| 86580 |
|
17 |
13 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
18 |
17 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
12 |
12 |
$0.00 |
| 90380 |
|
126 |
120 |
$0.00 |